Answers are grounded in this paper and cite their sources.
A 67-year old female with metastatic EGFR mutation positive lung cancer was treated with osimertinib and had a clinical and radiographic response. She developed thrombocytopenia and experienced several embolic events, which subsequently led to the diagnosis of non-bacterial thrombotic endocarditis (NBTE). NBTE is a rare complication of cancer, generally occurring in the setting of uncontrolled malignancy. Treatment involves management of the underlying malignancy, anticoagulation, and supportive care.
No takes yet. Share an insight, caveat, or question.
Moore et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: